Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.75B |
| 2 |
NVIDIA
NVDA
|
+$1.34B |
| 3 |
Capital One
COF
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$1.01B |
| 5 |
Amazon
AMZN
|
+$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$496M |
| 4 |
Qualcomm
QCOM
|
+$469M |
| 5 |
Applovin
APP
|
+$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Cartesian Therapeutics
RNAC
$252M
| $2.28M | ﹤0.01% |
218,927
-6,573
| -3% | -$68.3K |
|
3102
Protara Therapeutics
TARA
$121M
| $2.26M | ﹤0.01% |
744,519
+397,822
| +115% | +$1.21M |
|
3103
Finward Bancorp
FNWD
$138M
| $2.26M | ﹤0.01% |
81,669
+40,778
| +100% | +$1.13M |
|
3104
Pro-Dex
PDEX
$108M
| $2.26M | ﹤0.01% |
51,668
+24,927
| +93% | +$1.09M |
|
3105
Lexicon Pharmaceuticals
LXRX
$418M
| $2.25M | ﹤0.01% |
2,377,694
-1,311,577
| -36% | -$1.24M |
|
3106
CVRx
CVRX
$205M
| $2.25M | ﹤0.01% |
382,437
+23,079
| +6% | +$136K |
|
|
SLDE
3107
Slide Insurance Holdings, Inc. Common Stock
SLDE
$1.81B
| $2.24M | ﹤0.01% |
+103,643
| New | +$2.24M |
|
3108
Complete Solaria, Inc. Common Stock
SPWR
$128M
| $2.22M | ﹤0.01% |
1,208,997
+753,168
| +165% | +$1.39M |
|
3109
Bilibili
BILI
$10.5B
| $2.22M | ﹤0.01% |
103,666
+713
| +0.7% | +$15.3K |
|
3110
Lineage Cell Therapeutics
LCTX
$306M
| $2.21M | ﹤0.01% |
2,431,619
-2,053,967
| -46% | -$1.86M |
|
3111
Sanara MedTech
SMTI
$302M
| $2.21M | ﹤0.01% |
77,739
-11,014
| -12% | -$313K |
|
3112
TMC The Metals Company
TMC
$2.24B
| $2.18M | ﹤0.01% |
330,823
+146,650
| +80% | +$968K |
|
3113
Stoneridge
SRI
$228M
| $2.18M | ﹤0.01% |
308,978
-329,654
| -52% | -$2.32M |
|
|
NGD
3114
New Gold Inc
NGD
$5.16B
| $2.17M | ﹤0.01% |
433,971
+13,544
| +3% | +$67.6K |
|
|
INGM
3115
Ingram Micro Holding Corporation
INGM
$4.93B
| $2.15M | ﹤0.01% |
103,184
+10,878
| +12% | +$227K |
|
|
CAN
3116
Canaan Creative
CAN
$387M
| $2.13M | ﹤0.01% |
3,452,553
+1,409,812
| +69% | +$872K |
|
3117
Nuvectis Pharma
NVCT
$157M
| $2.13M | ﹤0.01% |
285,332
+149,999
| +111% | +$1.12M |
|
3118
Ericsson
ERIC
$26.4B
| $2.12M | ﹤0.01% |
250,389
+1,658
| +0.7% | +$14.1K |
|
3119
Marine Products Corp
MPX
$316M
| $2.11M | ﹤0.01% |
248,087
+2,464
| +1% | +$21K |
|
3120
NI Holdings
NODK
$276M
| $2.11M | ﹤0.01% |
165,710
-7,763
| -4% | -$98.9K |
|
3121
Star Bulk Carriers
SBLK
$2.2B
| $2.11M | ﹤0.01% |
122,115
+2,748
| +2% | +$47.4K |
|
3122
Alvotech
ALVO
$2.5B
| $2.1M | ﹤0.01% |
230,291
+1,574
| +0.7% | +$14.4K |
|
3123
GrafTech
EAF
$261M
| $2.09M | ﹤0.01% |
215,092
-294,892
| -58% | -$2.87M |
|
3124
Consumer Portfolio Services
CPSS
$190M
| $2.09M | ﹤0.01% |
212,555
+16,563
| +8% | +$163K |
|
3125
Inhibikase Therapeutics
IKT
$116M
| $2.08M | ﹤0.01% |
1,066,700
+741,940
| +228% | +$1.45M |
|